HRSA-22-024: Ryan White HIV/AIDS Program (RWHAP) Access, Care, and Engagement Technical Assistance Center (ACE TA Center)
Closed
This grant is closed. A newer notice from the same program is forecast: Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program Training and Technical Assistance (HRSA-27-078). Status: Expected deadline January 20, 2027. It is in our archive of Health Resources and Services Administration notices from 2021.
Health Resources and Services Administration offered grants to nonprofits, colleges and universities, state and local governments and tribes. It expected to make one award worth $375,000 in total. Applications closed on January 21, 2022.
From the official notice on Grants.gov, last changed October 18, 2021. Checked November 7, 2026.
- Total funding$375,000
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | October 18, 2021 |
|---|---|
| Deadline | January 21, 2022 |
| Archived by Grants.gov | March 22, 2022 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments and tribes.
- State governments
- Native American tribal governments (Federally recognized)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible organizations include national organizations; state, local, and Indian tribal governments; institutions of higher education; other non-profit organizations (including faith-based, community-based, and tribal organizations); and academic health science centers.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity to apply for funding under the Ryan White HIV/AIDS Program (RWHAP) Access, Care and Engagement Technical Assistance Center (ACE TA Center), previously funded under Funding Opportunity Number HRSA-19-030. This cooperative agreement will build the capacity of RWHAP recipients and subrecipients to ensure people with HIV understand and use the range of health care coverage options available to facilitate access to and maintain engagement in care. The funded entity will work collaboratively with Health Resources and Services Administration’s (HRSA) HIV/AIDS Bureau (HAB) on a national scale to achieve the following goals: (1) Maximize engagement of people with HIV in health care through increased health literacy on how to access and engage with the health care system, including clinicians, support service providers, and other practitioners. (2) Increase awareness and understanding of RWHAP recipients, subrecipients, providers, and people with HIV on how to enroll in and/or utilize health care coverage options available in the evolving health care landscape. (3) Identify or develop strategies and messages to promote equitable access to health care coverage options for people with HIV to increase engagement in HIV care and maintain health care coverage through the assistance of outreach workers; health educators; case managers; peer navigators; health care navigators; certified application counselors, and other assisters; and administrators. (4) Improve health outcomes across the HIV care continuum for people with HIV, including maximizing health care coverage for people aging with HIV.
Who has won HIV-Related Training and Technical Assistance grants before
From fiscal 2021 to 2025, HIV-Related Training and Technical Assistance (93.145) awarded $599 million across 587 grant awards, an average of $1.0 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Regents of the University of California, San Francisco | California | 7 | $31.0 million |
| Vanderbilt University Medical Center | Tennessee | 3 | $23.4 million |
| The Trustees of Columbia University in the City of New York | New York | 3 | $22.0 million |
| University of Illinois | Illinois | 6 | $21.7 million |
| University of Washington | Washington | 4 | $19.0 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-078, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-22-024 still open?
No. It closed on January 21, 2022. A newer notice is forecast: HRSA-27-078, expected deadline January 20, 2027.
Who can apply for Ryan White HIV/AIDS Program (RWHAP) Access, Care, and Engagement Technical Assistance Center (ACE TA Center)?
Health Resources and Services Administration accepted applications from nonprofits, colleges and universities, state and local governments and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Ryan White HIV/AIDS Program (RWHAP) Access, Care, and Engagement Technical Assistance Center (ACE TA Center)?
Closed January 21, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $375,000 in total for one award.
Who has won HIV-Related Training and Technical Assistance grants before?
The largest recipients over five fiscal years were The Regents of the University of California, San Francisco, Vanderbilt University Medical Center, The Trustees of Columbia University in the City of New York. The program made 587 awards worth $599 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)